Dr. Reddy's Laboratories (Switzerland)

Recent papers from Dr. Reddy's Laboratories (Switzerland)

1. Deep mutational learning for the selection of therapeutic antibodies resistant to the evolution of Omicron variants of SARS-CoV-2Nature Biomedical Engineering · 2025
2. Rituximab pharmacokinetic and pharmacokinetic–pharmacodynamic evaluation based on a study in diffuse large B‐cell lymphoma: Influence of tumor size on pharmacokinetic and assessment of pharmacokinetic similarityCPT Pharmacometrics & Systems Pharmacology · 2022
3. DeepSARS: simultaneous diagnostic detection and genomic surveillance of SARS-CoV-2BMC Genomics · 2022
4. Pharmacokinetics of Bio-shell-silver-core Nanoparticles (AgNP) in Sprague-Dawley Rats - In Vivo StudyPharmaceutical Nanotechnology · 2021
5. Pharmacokinetic Similarity and Comparative Pharmacodynamics, Safety, Efficacy, and Immunogenicity of DRL_RI Versus Reference Rituximab in Biologics-Naïve Patients with Moderate-to-Severe Rheumatoid Arthritis: A Double-Blind, Randomized, Three-Arm StudyBioDrugs · 2020
6. Randomized, Double-Blind, Pharmacokinetic Equivalence Trial Comparing DRL-Rituximab With MabThera in Patients With Diffuse Large B-Cell LymphomaJournal of Global Oncology · 2019
7. Sensitivity of Pegfilgrastim Pharmacokinetic and Pharmacodynamic Parameters to Product Differences in Similarity StudiesThe AAPS Journal · 2019
8. Target site pharmacokinetics of doxycycline for rosacea in healthy volunteers is independent of the food effectBritish Journal of Clinical Pharmacology · 2018
9. A comparative pharmacokinetic study of DRL_BZ, a candidate biosimilar of bevacizumab, with Avastin® (EU and US) in healthy male subjectsBritish Journal of Clinical Pharmacology · 2018
10. Pharmacokinetics of DFN-15, a Novel Oral Solution of Celecoxib, Versus Celecoxib 400-mg Capsules: A Randomized Crossover Study in Fasting Healthy VolunteersClinical Drug Investigation · 2017
11. Pharmacokinetic Characterization and Dose Selection of a Novel Sumatriptan Nasal Spray Formulation, DFN‐02The Journal of Clinical Pharmacology · 2017
12. Comparison of Pharmacokinetics and Pharmacodynamics of Two Anti-CD20 Monoclonal Antibodies (Candidate Biosimilar DRL-Rituximab and Innovator Reference Product Rituximab (Mabthera®) in a Randomised, Multi-Centre, Double-Blind, Parallel Group Study of CHOP with Rituximab Chemotherapy in Patients with CD20-Positive Diffuse Large B-Cell LymphomaBlood · 2016
13. Expression of the α1b-Adrenergic Receptor and G Protein Subunits in Mammalian Cell Lines Using the Semliki Forest Virus Expression SystemJournal of Receptors and Signal Transduction · 1999